Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Oct 14, 2026, 4:37 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Showing 145–160 of 160 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Chronic Lung Disease of Prematurity Clear all

Conditions: Preterm Infant, BPD - Bronchopulmonary Dysplasia, Barotrauma
Interventions: NAVA, NIPPV; Other
Lead sponsor: University of Florida; Other
Eligibility: 24 Weeks to 32 Weeks
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2019
U.S. locations: 1
States / cities: Jacksonville, Florida

Conditions: Bronchopulmonary Dysplasia
Interventions: Synchronized HFNC at 6 liters per minute (LPM), Continuous HFNC at 6 liters per minute (LPM), Synchronized HFNC at 8 liters per minute (LPM), Continuous HFNC at 8 liters per minute (LPM); Other
Lead sponsor: University of Arkansas; Other
Eligibility: 28 Days to 1 Year
Enrollment: 1 participant
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2021
U.S. locations: 1
States / cities: Little Rock, Arkansas

Conditions: Bronchopulmonary Dysplasia
Interventions: Alvesco Inhalant Product; Drug
Lead sponsor: Venkatesh Sampath; Other
Eligibility: 8 Days to 35 Days
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2027
U.S. locations: 1
States / cities: Kansas City, Missouri

Conditions: Bronchopulmonary Dysplasia
Interventions: Infasurf surfactant (ONY, Inc.), Sham (No Treatment); Drug
Lead sponsor: Roberta Ballard; Other
Eligibility: 7 Days to 14 Days
Enrollment: 511 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2016
U.S. locations: 21
States / cities: Little Rock, Arkansas • Berkeley, California • Oakland, California + 15 more

Conditions: Patent Ductus Arteriosus, Preterm Infant, Bronchopulmonary Dysplasia
Interventions: Ibuprofen and acetaminophen, Ibuprofen and placebo; Drug
Lead sponsor: University of South Alabama; Other
Eligibility: 5 Days to 21 Days
Enrollment: 1 participant
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2020
U.S. locations: 1
States / cities: Mobile, Alabama

Conditions: Respiratory Insufficiency of Prematurity
Interventions: nCPAP, NIPPV; Device
Lead sponsor: McMaster University; Other
Eligibility: Up to 28 Days
Enrollment: 1,011 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2011
U.S. locations: 14
States / cities: Washington D.C., District of Columbia • Boston, Massachusetts • Voorhees Township, New Jersey + 6 more

Conditions: Bronchopulmonary Dysplasia, Chronic Lung Disease of Prematurity, Chronic Lung Disease
Interventions: LOWER oxygen saturation target group, HIGHER oxygen saturation target group; Other
Lead sponsor: Children's Hospital of Philadelphia; Other
Eligibility: 34 Weeks to 44 Weeks
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2023
U.S. locations: 3
States / cities: Philadelphia, Pennsylvania

Conditions: Bronchopulmonary Dysplasia, Prematurity
Interventions: Care coordination by telephone contacts with a nurse; Procedure
Lead sponsor: Wake Forest University; Other
Eligibility: 1 Day to 483 Days
Enrollment: 150 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 1996 – 2000
U.S. locations: 1
States / cities: Winston-Salem, North Carolina

Conditions: Preterm Infants, Respiratory Distress Syndrome (Neonatal), BPD - Bronchopulmonary Dysplasia
Interventions: Pressure Targeted High Flow, CPAP; Procedure
Lead sponsor: University of Texas at Austin; Other
Eligibility: 7 Days to 40 Weeks
Enrollment: 78 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 2
States / cities: San Diego, California • Austin, Texas

Conditions: Bronchopulmonary Dysplasia, Gastroesophageal Reflux
Interventions: Transpyloric tube feeding, Gastric tube feeding; Other
Lead sponsor: Children's Hospital of Philadelphia; Other
Eligibility: 1 Month to 12 Months
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2027
U.S. locations: 4
States / cities: Palo Alto, California • Denver, Colorado • Kansas City, Missouri + 1 more

Conditions: Premature Birth, Bronchopulmonary Dysplasia, Asthma
Interventions: Not listed
Lead sponsor: Indiana University; Other
Eligibility: 2 Months to 36 Months
Enrollment: 104 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2007 – 2019
U.S. locations: 1
States / cities: Indianapolis, Indiana

Conditions: Severe Bronchopulmonary Dysplasia
Interventions: Albuterol Sulfate, Sterile Saline; Drug
Lead sponsor: Children's Hospital of Philadelphia; Other
Eligibility: Up to 1 Year
Enrollment: 24 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2018
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Prematurity; Extreme, Feeding Patterns, Ventilator Lung; Newborn
Interventions: Continuous Feeds, Intermittent Bolus Feeds; Other
Lead sponsor: Rajeev Kumar; Government
Eligibility: Not listed
Enrollment: 46 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2025
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Sepsis, Bronchopulmonary Dysplasia, Necrotizing Enterocolitis, Retinopathy of Prematurity, Systemic Inflammatory Response Syndrome
Interventions: Parenteral cysteine-HCl supplementation, Placebo - added premasol; Dietary Supplement
Lead sponsor: University of California, Los Angeles; Other
Eligibility: Up to 30 Days
Enrollment: 108 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2011
U.S. locations: 1
States / cities: Los Angeles, California

Conditions: Bronchopulmonary Dysplasia, Pulmonary Hypertension Due to Lung Diseases and Hypoxia, Extreme Prematurity, Ventilator Lung; Newborn, Ventilation Perfusion Mismatch
Interventions: Increase in the PEEP followed by decrease in the PEEP, Decrease in the PEEP followed by increase in the PEEP; Other
Lead sponsor: University of Alabama at Birmingham; Other
Eligibility: 7 Days to 30 Days
Enrollment: 24 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Birmingham, Alabama

Conditions: Healthy, Cystic Fibrosis (CF), Asthma, Bronchopulmonary Dysplasia (BPD)
Interventions: Hyperpolarized Helium-3 MRI of the chest; Drug
Lead sponsor: University of Virginia; Other
Eligibility: 4 Months to 65 Years
Enrollment: 45 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2011 – 2018
U.S. locations: 1
States / cities: Charlottesville, Virginia

Search by objective public record fields.

Comparison of Primary Extubation Failure Between NIPPV and NI-NAVA

Effect of Synchronized vs. Continuous HFNC Using NAVA on WOB in Infants With BPD

Inhaled Ciclesonide Study in Preterm Infants

Trial of Late Surfactant for Prevention of Bronchopulmonary Dysplasia

Randomized Controlled Trial to Evaluate the Safety and Efficacy of Acetaminophen in Preterm Infants Used in Combination With Ibuprofen for Closure of the Ductus Arteriosus

Nasal Intermittent Positive Pressure Ventilation in Premature Infants (NIPPV)

BPD Saturation TARgeting

Post-hospitalization Nursing Effectiveness (PHONE) Study

Pressure Targeting During High Flow Therapy in Premature Infants

Transpyloric Versus Gastric Feeding in Bronchopulmonary Dysplasia

Assessment of Lung Structure and Function of Infants Born Prematurely

Aerosolized Albuterol Use in Severe BPD

To Determine the Best Feeding Practice in Preterm Infants on Non-invasive Ventilation.

Cysteine Supplementation in Critically Ill Neonates

Ventilator Pressure and Optimization of Compliance and Hemodynamics

MRI for Non-Invasive Imaging in Neonates and Children